Autoimmune Type 1 Diabetes: Resolved and Unresolved Issues

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2001 Nov 7

PMID 11696564

Citations 98

Authors

A L Notkins

A Lernmark

Affiliations

Soon will be listed here.

Citing Articles

The role of GABA in type 1 diabetes.

Mick G, McCormick K Front Endocrinol (Lausanne). 2024; 15:1453396.

PMID: 39619323 PMC: 11604429. DOI: 10.3389/fendo.2024.1453396.

Benchmarking enrichment analysis methods with the disease pathway network.

Buzzao D, Castresana-Aguirre M, Guala D, Sonnhammer E Brief Bioinform. 2024; 25(2).

PMID: 38436561 PMC: 10939300. DOI: 10.1093/bib/bbae069.

New-Onset Diabetes Mellitus in COVID-19: A Scoping Review.

Pantea Stoian A, Bica I, Salmen T, Al Mahmeed W, Al-Rasadi K, Al-Alawi K Diabetes Ther. 2023; 15(1):33-60.

PMID: 37751143 PMC: 10786767. DOI: 10.1007/s13300-023-01465-7.

A randomized trial of oral gamma aminobutyric acid (GABA) or the combination of GABA with glutamic acid decarboxylase (GAD) on pancreatic islet endocrine function in children with newly diagnosed type 1 diabetes.

Martin A, Mick G, Choat H, Lunsford A, Tse H, McGwin Jr G Nat Commun. 2022; 13(1):7928.

PMID: 36566274 PMC: 9790014. DOI: 10.1038/s41467-022-35544-3.

The IGFBP3/TMEM219 pathway regulates beta cell homeostasis.

DAddio F, Maestroni A, Assi E, Ben Nasr M, Amabile G, Usuelli V Nat Commun. 2022; 13(1):684.

PMID: 35115561 PMC: 8813914. DOI: 10.1038/s41467-022-28360-2.

References

Jun H, Kang Y, Notkins A, Yoon J . Gain or loss of diabetogenicity resulting from a single point mutation in recombinant encephalomyocarditis virus. J Virol. 1997; 71(12):9782-5. PMC: 230289. DOI: 10.1128/JVI.71.12.9782-9785.1997. View

Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay I . UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet. 1997; 350(9087):1288-93. DOI: 10.1016/s0140-6736(97)03062-6. View

Gottlieb P, Eisenbarth G . Diagnosis and treatment of pre-insulin dependent diabetes. Annu Rev Med. 1998; 49:391-405. DOI: 10.1146/annurev.med.49.1.391. View

Schranz D, Lernmark A . Immunology in diabetes: an update. Diabetes Metab Rev. 1998; 14(1):3-29. DOI: 10.1002/(sici)1099-0895(199803)14:1<3::aid-dmr206>3.0.co;2-t. View

Schranz D, Bekris L, Landin-Olsson M, Torn C, Nilang A, Toll A . A simple and rapid microSepharose assay for GAD65 and ICA512 autoantibodies in diabetes. Diabetes Incidence Study in Sweden (DISS). J Immunol Methods. 1998; 213(1):87-97. DOI: 10.1016/s0022-1759(98)00025-8. View

Ilonen J, Simell O, Knip M, Akerblom H . Screening for genetic IDDM risk and prevention trials in infancy. Diabetes Metab Rev. 1998; 14(2):188. DOI: 10.1002/(sici)1099-0895(199806)14:2<188::aid-dmr1210>3.0.co;2-0. View

Nepom G, Kwok W . Molecular basis for HLA-DQ associations with IDDM. Diabetes. 1998; 47(8):1177-84. DOI: 10.2337/diab.47.8.1177. View

Mauricio D, Mandrup-Poulsen T . Apoptosis and the pathogenesis of IDDM: a question of life and death. Diabetes. 1998; 47(10):1537-43. DOI: 10.2337/diabetes.47.10.1537. View

Verge C, Stenger D, Bonifacio E, Colman P, Pilcher C, Bingley P . Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes. 1998; 47(12):1857-66. DOI: 10.2337/diabetes.47.12.1857. View

10.

Leslie R, Atkinson M, Notkins A . Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes. Diabetologia. 1999; 42(1):3-14. DOI: 10.1007/s001250051105. View

11.

Littorin B, Sundkvist G, Hagopian W, Landin-Olsson M, Lernmark A, Ostman J . Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes. Diabetes Care. 1999; 22(3):409-12. DOI: 10.2337/diacare.22.3.409. View

12.

Todd J . From genome to aetiology in a multifactorial disease, type 1 diabetes. Bioessays. 1999; 21(2):164-74. DOI: 10.1002/(SICI)1521-1878(199902)21:2<164::AID-BIES10>3.0.CO;2-4. View

13.

Graham J, Kockum I, Sanjeevi C, Landin-Olsson M, Nystrom L, Sundkvist G . Negative association between type 1 diabetes and HLA DQB1*0602-DQA1*0102 is attenuated with age at onset. Swedish Childhood Diabetes Study Group. Eur J Immunogenet. 1999; 26(2-3):117-27. View

14.

Knip M, Akerblom H . Environmental factors in the pathogenesis of type 1 diabetes mellitus. Exp Clin Endocrinol Diabetes. 1999; 107 Suppl 3:S93-100. DOI: 10.1055/s-0029-1212160. View

15.

Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y . A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med. 2000; 342(5):301-7. DOI: 10.1056/NEJM200002033420501. View

16.

Hawa M, Fava D, Medici F, Deng Y, Notkins A, De Mattia G . Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality. Diabetes Care. 2000; 23(2):228-33. DOI: 10.2337/diacare.23.2.228. View

17.

Potter K, Wilkin T . The molecular specificity of insulin autoantibodies. Diabetes Metab Res Rev. 2000; 16(5):338-53. DOI: 10.1002/1520-7560(2000)9999:9999<::aid-dmrr145>3.0.co;2-l. View

18.

Mire-Sluis A, Das R, Lernmark A . The World Health Organization International Collaborative Study for islet cell antibodies. Diabetologia. 2000; 43(10):1282-92. DOI: 10.1007/s001250051524. View

19.

Cai T, Krause M, Odenwald W, Toyama R, Notkins A . The IA-2 gene family: homologs in Caenorhabditis elegans, Drosophila and zebrafish. Diabetologia. 2001; 44(1):81-8. DOI: 10.1007/s001250051583. View

20.

Jun H, Yoon J . The role of viruses in type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals. Diabetologia. 2001; 44(3):271-85. DOI: 10.1007/s001250051614. View